Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. (2021)
Attributed to:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2021.02.033
PubMed Identifier: 33743891
Publication URI: http://europepmc.org/abstract/MED/33743891
Type: Journal Article/Review
Volume: 184
Parent Publication: Cell
Issue: 8
ISSN: 0092-8674